Delivery Order SPE2DB24D1201-SPE2DB25FJCEL

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $9,453.90 and a period of performance through January 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $17,083.42 and an ultimate completion date of January 22, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has an ultimate completion date of April 1, 2025 and a ceiling value of $6,266.60. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $50,931.42 and a period of performance through May 15, 2025. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $16,967.66 and a performance period that runs through March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract has a ceiling value of $6,833.38 and a period of performance through April 7, 2025. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $14,256.34 and runs through March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $46,743.33 and a period of performance through March 20, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty medication. The contract has a ceiling value of $1,717.48 and a period of performance through April 1, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $25,876.13 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a period of performance through March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJCEL
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $3,579.73 and an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/8/25, 2:18 PM